Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond

COVID-19 has proved enormously disruptive to the provision of cancer screening, which does not just represent an initial test but an entire process, including risk detection, diagnostic follow-up, and treatment. Successful delivery of services at all points in the process has been negatively affecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Croswell, Jennifer M., Corley, Douglas A., Lafata, Jennifer Elston, Haas, Jennifer S., Inadomi, John M., Kamineni, Aruna, Ritzwoller, Debra P., Vachani, Anil, Zheng, Yingye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722181/
https://www.ncbi.nlm.nih.gov/pubmed/34217414
http://dx.doi.org/10.1016/j.ypmed.2021.106595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722181/
https://www.ncbi.nlm.nih.gov/pubmed/34217414
http://dx.doi.org/10.1016/j.ypmed.2021.106595

Ejemplares similares